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Presymptomatic DNA testing is embedded in genetic counselling and is usually offered by clinical genetics departments in university hospitals. On the basis of the Huntington's disease protocol, this type of DNA testing in the Netherlands traditionally requires at least two counselling sessions, including face-to-face disclosure of the test results (1) . However, there is an increasing demand from our patients for more freedom of choice within the procedure. Specifically, a substantial group of patients wants to learn their DNA result by letter, followed by an optional extensive counselling session if a mutation is found. They argue that they would prefer to deal with the first emotions after disclosure of the DNA result in a private setting and have a counselling appointment several days later. They also indicate that having to travel long distances and take time off work was unnecessary if the result was favourable.
The traditional counselling model for presymptomatic DNA testing, including face-to-face disclosure of the result, was developed for Huntington's disease, an untreatable degenerative neurological disorder (2) . Strictly following this counselling model might unnecessarily restrict the freedom of choice for patients tested for syndromes that are, to some extent, treatable and preventable, e.g. BRCA1 and BRCA2 associated hereditary breast-ovarian cancer and Lynch syndrome hereditary colorectal cancer (3) . A less strict protocol may be defendable because it has been well documented that the psychological impact of DNA testing in these disorders is limited (4) (5) (6) (7) (8) (9) (10) (11) . As patient autonomy is increasingly one of the corner stones of good clinical practice, limiting a patient's choice on how to be given the DNA result must be based on evidence. We therefore decided to investigate whether disclosing a DNA result by letter instead of face-to-face had any effect in terms of psychological harm and, more generally, in terms of the quality of genetic counselling and patient satisfaction. Although an alternative approach of counselling by phone has been investigated in hereditary cancer (12) (13) (14) , no studies on disclosing the result by letter have been published so far. The results for counselling by phone turned out to be positive. Counselees were more satisfied when they got the choice between disclosure by phone or in a face-to-face consultation, than if the result was only given face-to-face (12) . Disclosure by phone did not negatively affect their knowledge about the disease, psychological functioning or satisfaction. Anxiety was not higher after hearing the result by phone (13) . When offered a choice, counselees chose disclosure by phone more often than face-to-face (13, 14) . Disclosure by phone was cheaper because it took less travel-and consultation time for both counsellor and counselee.
Here, we report on the quality of counselling for patients at risk of having a familial mutation in BRCA1, BRCA2 or one of the Lynch syndrome genes; we compared the traditional procedure with one that provides a choice of how the test result was disclosed (by letter or face-to-face).
The quality of the genetic counselling was assessed by measuring the counselees' knowledge about the disease, decision-making processes, risk perception, personal control, psychological functioning and satisfaction. For these six quality aspects there have been formulated two hypotheses:
(1) Between both variants of the result disclosure protocols there will be no difference in the first five mentioned quality aspects of the genetic counselling; the satisfaction about the result disclosure will be greater in the choice variant. (2) The result of the DNA test (favourable vs unfavourable result) will have an influence on the satisfaction: the satisfaction about the result disclosure will be the lowest when there is a favourable result and the result has been given following the standard protocol.
Materials and methods

General procedure
Participants were recruited between September 2007 and December 2010. All counselees referred to the clinical genetics department at the University Medical Center Groningen (UMCG) because a germline mutation in the BRCA1 or BRCA2 gene or in one of the Lynch syndrome-associated genes had been identified in their family, were eligible. This means that counselees from families with unexplained variants were not included. Together with an invitation letter for the intake session and the usual general information leaflets on the procedure of genetic counselling and on family history retrieval, the counselees were sent information about our study with an informed consent form and a first questionnaire. The rationale for the study, tailoring the disclosure of DNA test results to the needs and wishes of the counselees, was formulated in the invitation letter. It was made clear that participation in this study would in no way affect their eligibility for DNA testing and counselling. Participants who agreed to participate knew they had to complete questionnaires at three time points: before the intake (T1), 2-3 days after receiving the DNA result (T2), and 4-6 weeks later (T3).
There was a period of 2-6 weeks between the invitation and intake session, and 5-7 weeks between the intake and result of the DNA test. Counselees who had not returned an informed consent form 2 weeks before the intake were reminded by phone that they could take part in the study. The study was approved by the UMCG institutional board.
Study population
Almost all the participants had a 50% chance of having a familial BRCA1/2 or Lynch syndrome mutation. For the inclusion into our study, participants had to be pre-symptomatic (no cancer in the past) and speak sufficient Dutch. The Lynch syndrome group consisted of both men and women of 18 years and older, while the BRCA1/2 group consisted of women aged 25 and older, because the younger women were already participating in another study. The exclusion criteria are mentioned in the flow chart ( Figure 1 ). Of 346 counselees who were invited to participate, 246 returned questionnaire T1 (71.1%). The best way to test our hypotheses is running a randomized controlled trial, where all the counselees are randomly assigned into either the traditional or choice group. In the traditional protocol, an appointment for a face-toface session is planned when the DNA test result is available. Those in the choice protocol were informed about the pros and cons of either option (i.e. result disclosed face-to-face or disclosure by letter with a subsequent face-to-face appointment with a genetic counsellor within 1 week) in a standardised way during the intake. Those who chose for disclosure at the department got an appointment when the DNA test result was available. Those who opted for disclosure by letter, received a concise letter containing the DNA test result as well as an appointment within 1 week to discuss the results face-to-face. In this letter, it was formulated that they could contact us to cancel the planned faceto-face appointment if they wished to, in which case they would get a second letter with a more extensive conclusion, written in such a way that it would also be comprehensible for their general practitioner (GP) and their children. This conclusive letter to the counselee is standard care in genetic counselling in the Netherlands. The disclosure letter was written and signed by their 'own' genetic counsellor or clinical geneticist and included their phone number to give immediate access if needed. In total, 165 counselees returned questionnaire T2 (47.7%). Because the traditional and choice protocol were compared at each measuring point separately (T1, T2 and T3), counselees could be included if they only returned the first and second questionnaires (24 counselees) or only the first and third questionnaires (14 counselees). One hundred twenty-seven counselees returned all three questionnaires. After T1, 48 counselees were excluded at the intake session and we had 33 drop-outs occurred during the course of the study (Figure 1 ). At T1, sociodemographic data were obtained on gender, age, marital status, number of children and education level.
Assessing the quality of genetic counselling
Personal control
The perceived personal control (PPC) questionnaire assesses how much personal control people experience as a counselee and is a valid measure for the evaluation of genetic counselling outcomes (15, 16) . All nine items were counted and used as an indicator of personal control. The internal consistency was high in this sample [Cronbach's α of 0.82 (T1), 0.85 (T2) and 0.85 (T3)].
Knowledge, risk perception and decision-making
These questionnaires were based on those developed for the breast cancer risk communication (BRISC) study, a study of risk perception in hereditary cancer counselling using different risk format ways (17) . For the knowledge questionnaire, participants needed to answer eight statements on hereditary cancer and three questions about risk percentages for 'cancer in general', 'a predisposition to hereditary cancer' and 'getting cancer when having a predisposition to hereditary cancer'. The total score could range from 0 to 11. A higher score indicates more knowledge about hereditary cancer. The internal consistency was moderate in this sample (Cronbach's α of 0.65, 0.60 and 0.61).
The risk perception questionnaire had seven items. Participants had to state how risky they found the percentages mentioned, to estimate their own chance of getting cancer, and the anxiety they experienced about it on a seven-point scale. The total score could range from 0 to 49. A higher score indicates a higher risk perception. The internal consistency was good (Cronbach's α of 0.85, 0.86 and 0.85).
For the decision-making questionnaire, participants had to indicate how far they would be willing to follow Table 1 . Questions on satisfaction with the counselling process in general (1) (2) (3) (4) (5) (6) (9) (10) and the procedure for disclosing the DNA result (7-8)
1.
How far have your expectations and/or needs been met? 2.
How actively were you involved in the procedure (e.g. could you ask the questions you wanted to ask)? 3.
How satisfied are you with the information you received during the procedure? 4.
How satisfied are you with the practical and emotional support you received during the procedure? 5.
Do you feel the counsellor had enough time for you? 6.
How satisfied are you, in total, about the procedure? 7.
How satisfied are you about the way in which the result of the DNA test was disclosed to you? 8.
How high would you score the way you received the result? 9.
How satisfied are you with the written report? 10.
How satisfied are you about the reception at the department and the way you were treated? (19, 20) . This scale includes questions on worries about getting cancer, influence on mood, restrictions in daily activities, and worries about the occurrence of cancer by family members on 4-point scales ranging from 'almost never' to 'almost always'. The total score could range from 0 to 4. A higher score indicates more worries about getting cancer. The internal consistency of the CWS in our study population was low (Cronbach's α of 0.58, 0.50 and 0.53), which means that the results have to be interpreted with caution.
Satisfaction
This questionnaire was derived from the QUOTEgene ca (Quality of care through the patient's eyes) scale (21) . It assesses counselees' opinion on the quality and satisfaction of the counselling procedure. Eight items were used and supplemented with two specific items about the procedure for disclosing the test result (questions 7 and 8; see Table 1 ). Participants could indicate their satisfaction on visual analogue scales between 0 and 10. A higher score indicates more satisfaction. The items for 'general satisfaction' and 'disclosure satisfaction' were analysed separately. The internal consistency was good for general satisfaction [Cronbach's α of 0.92 (T2) and 0.90 (T3)] and moderate to good for disclosure satisfaction [Cronbach's α of 0.78 and 0.68, respectively).
Statistical analyses
First, we compared the pre-test (T1) scores in the choice group to the traditional group for the demographic and dependent variables. Second, we checked differences for the same variables between the participants and the drop-outs. We used the chi-square test for the demographic data and the independent t-test for age and the dependent variables. The groups were compared at T2 and T3, with the disclosure protocol (choice protocol vs traditional protocol) and the DNA result (favourable vs unfavourable) as independent variables. An anova with a 2 × 2 factorial design in spss16 was used for these analyses.
Results
Pre-test analyses
For the pre-test measurements, we excluded the data from 48 participants, as these participants were excluded later in the study and differ from our final study sample (Figure 1 ). Thus, 198 cases were included at T1, 99 in the traditional protocol group and 99 in the choice group. Participants in the choice group were significantly older than the participants in the traditional group (M = 47.08, SD = 13.55 vs M = 42.09, SD = 13.34, t (142) = −2.58, p < 0.05), and they more often had children (86.9 vs 69.7%, χ 2 (1) = 8.59, p < 0.05).
In the traditional group, there were significantly more Lynch syndrome counselees than in the choice group (23.2 vs 11.1%, χ 2 (1) = 5.11, p < 0.05), see Table 2 . No significant differences were found between the traditional and choice groups for dependent variables at T1 (Table 2) , so no corrections for pre-test differences in further analyses were necessary. The number of Lynch cases and the number of male cases was too small to perform separate subgroup analyses.
Drop-outs
We found no significant differences between the 165 participants who had returned two or more questionnaires and the 33 drop-outs in the demographic and dependent variables at T1. The number of drop-outs in the two groups did not differ significantly: 17 in the traditional group and 16 in the choice group.
The quality of genetic counselling
The disclosure procedure had no influence on counselees' knowledge about the disease, decision-making, risk perception or psychological functioning (Table 3) . There was no difference in personal control directly after DNA test disclosure (T2), but at follow-up (T3) counselees in the traditional group felt they had more control on their life than counselees in the choice group. The effect size was small to average (F (1, 126) = 6.62, p < 0.05, r = 0.22). To explain this unexpected result, we looked at the influence of disclosure type (by letter or face-to-face) and at the result (favourable or unfavourable) on personal control in the choice group at follow-up. However, the feeling of control did not depend on how the result was disclosed in the choice group (M = 1.35, SD = 0.49 vs M = 1.50, SD = 0.56, t (67) = −1.11, p = n.s), nor on the test result (favourable or unfavourable) (M = 1.43, SD = 0.48 vs M = 1.60, SD = 0.39, F (1, 126) = 3.61, p = n.s).
Patient satisfaction
Satisfaction scores were generally very high. The scores were always higher in the choice group, especially at T3, but only reached significance in the general satisfaction with the genetic counselling process at follow-up ( Table 3 ). The effect size was small to average (M = 8.02, SD = 1.13 vs M = 8.59, SD = 0.97, F (1, 130) = 4.62, p < .05, r = 0.18). In Table 4 , the results for satisfaction are given for each group, and are split up for both favourable and unfavourable results. There were three significant interaction effects. The satisfaction with the general genetic counselling process shortly after result disclosure (T2) did not differ between the traditional group and the choice group, regardless of the test result. However, at follow-up (T3) there was a significant difference in overall satisfaction (F (1, 130) = 5.34, p < 0.05, r = 0.20), with a good DNA result being the decisive factor. Regarding the satisfaction with the disclosure procedure, there was a significant difference at T2 (F (1, 143) = 4.87, p < 0.05, r = 0.18) and at T3 (F(1, 133) = 6.24, p < 0.05, r = 0.21) between the counselees in the traditional group and the choice group, again correlated to the result. The effect sizes were small to average. The interaction diagrams (Figure 2) show that counselees with a favourable result in the choice group were more satisfied with the disclosure procedure than all the other counselees. This difference is clear both at T2 and at T3. A similar pattern can be seen in general satisfaction with the overall genetic counselling procedure.
Counselees with a favourable result in the choice group were more satisfied with the predictive DNA testing procedure than all the other counselees. This difference was not significant directly after the result was disclosed, but at follow-up it was ( Table 4 ).
The choice of disclosure procedure and subsequent appointments
In the choice protocol group, at the end of the intake session the counselee was informed about both options in a standard way after which she/he had to choose how to have the DNA test result disclosed. Of the 83 counselees in the choice group, 26 (31%) wanted to hear their result from the genetics counsellor in a face-to-face consultation, while 57 (69%) chose to receive their result by letter. There were no significant differences on dependent and demographical variables between the counselees who chose for a disclosure face-to-face and the counselees who chose for a disclosure by letter.
Of those who received the result by letter, 18 (32%) appeared to be mutation carriers and 39 (68%) had a favourable DNA result. All the counselees who appeared to have the mutation came to the subsequent consultation with the counsellor to discuss the result extensively. All but one of the counselees in whom the familial mutation had been excluded (n = 38) cancelled the face-to-face appointment. The one counselee who kept his appointment did so because of an unrelated familial disorder for which he wanted additional genetic counselling.
Discussion
Nearly, 70% of the counselees who were offered a choice, opted to receive their test result by letter, which reflects a substantial preference for this procedure on the part of counselees. Our study shows that by using a choice protocol in which result disclosure by letter is combined with the offer of a face-to-face contact within several days, there is no indication of excess psychological harm or loss of counselling quality. Compared to the traditional procedure, patient satisfaction was generally higher when patients were offered a choice with respect to how the test result was disclosed. In addition, it turned out that nearly all the counselees who had chosen to have their result by letter, cancelled the planned face-to-face consultation if their result was favourable (i.e. no mutation found), thereby reducing the genetic counsellor's work load.
One of our assumptions was that satisfaction with the disclosure procedure would be higher in the choice protocol than in the traditional protocol, and that there would be no differences in the other quality aspects of the genetic counselling. Indeed, our results in both protocols showed minimal differences in all the quality aspects. As for satisfaction, we could identify only one main effect: at follow-up (T3), satisfaction with the whole counselling procedure was higher in the choice protocol group. However, it may be that the generally very high satisfaction scores created a 'ceiling effect' which impedes detection of significant differences.
We assumed that satisfaction with the disclosure procedure would be lowest for those with a favourable result and a mandatory face-to-face disclosure according to the traditional protocol. This effect was not found. However, the effect that we did find is very similar: counselees in the choice protocol group and with a favourable result were more satisfied with the disclosure procedure than those in all the other groups.
To our knowledge, this is the first study that explores the use of a letter for disclosing a DNA test result. However, as described in the introduction, some studies have been carried out on disclosure by telephone with counselees having a BRCA1/2 mutation risk (12) (13) (14) .
Disclosure by phone has the advantage that the counselee's reaction can be assessed in real time and the consequences of the test result can be discussed directly. However, based on our experience in counselling practice, there are some disadvantages as well. It can be difficult to reach people during working hours and to speak with them in a private and tranquil setting, even when the day and time of telephone disclosure are planned on forehand. A telephone conversation is also restricted to one counsellor and one counselee, significant others can rarely take part in the conversation at the moment of disclosure. In contrast, a letter can be opened by the counselee at a suitable moment and place; the test result can be formulated unequivocally, and the planned next appointment to discuss the test result is immediately available. However, the validity of these assumptions needs to be investigated by comparing the three ways of disclosure: by phone, letter or face-to-face.
One unexpected finding was that, at follow-up (T3), counselees in the traditional protocol group perceived more personal control than counselees in the choice group. Since neither the test result (favourable or unfavourable) nor the disclosure format (letter or faceto face) had influence on the PPC in the choice protocol group, and the effect was not present at T2, but only at follow-up, this might be a chance finding. It seems unlikely, that the introduction of an extra choice into the counselling procedure for pre-symptomatic DNA testing in hereditary cancer would lead to a feeling of less control, although it is possible that an extra choice moment generated additional stress. However, the counselees in the choice and traditional protocol groups did not differ in the GHQ measurement, showing that the stress level was equal between the groups.
A limitation of our study was that only 47.7% of all the participants approached returned two or three questionnaires. However, the fact that the drop-outs did not differ in demographic and dependent variables from the participants, makes it probably that our results can be generalised to the whole BRCA1/2 population, presuming that for men the procedure is relatively less intrusive then for women as they will not be confronted with preventive operation issues. Because the number of counselees with a risk of Lynch syndrome was small, generalization for this group cannot be made, although earlier studies show that the psychological impact of the counselling procedure is less for this population compared to the BRCA1/2 population (8) . A second limitation is that the effect sizes of the significant results were small to average. This is most probably because of the fact that the current, careful, counselling procedure already leads to a very high satisfaction amongst counselees. Changes, such as the introduction of a choice in the disclosure procedure can thus increase the satisfaction score only a little ('ceiling effect'). Nevertheless, to offer the choice of disclosure by letter will not only increase patient satisfaction but also enhance efficiency and use of time for both the counselee and the genetics counsellor. This was also obvious from the fact that 97.4% of the counselees with a favourable result disclosed by letter did not need a subsequent face-to-face meeting. This led to a significant reduction in the time needed for consultation, for both counsellor and counselee. The advantage for the latter are even bigger when geographical distances are large.
A point of attention is that our counselees came from families where the causative gene mutation had already been identified. Thus, no counselees with an 'unclear test result', 'uninformative test result' or 'variant type of result' were included in our study, which means that this aspect of DNA testing could not be addressed. These counselees could experience more stress than those who get an unambiguous test result (8, 22) . In addition, we did not include patients with a personal history of cancer or those with psychological/psychiatric problems in our study. Whether our results are applicable to these counselees needs to be investigated further. Long-term effects should still be investigated, although earlier research showed that the psychological impact of counselling over time does not increase and is related to pre-test distress (11, 23) . Although our study shows little need for consultation after a favourable result in our study group, we emphasise this option should always be given as sometimes counselees with a favourable result suffer adverse psychological effects such as survivor guilt (24) .
In this study, we only investigated the disclosure procedure to counselees with a risk of Lynch syndrome or a BRCA1/2 mutation. Although there are many forms of hereditary cancer, these are the most prevalent. It seems unlikely that other 'adult onset' hereditary cancer syndromes will require a different approach. In hereditary cancer syndromes where children are tested for mutations, e.g. FAP or MEN2A, a complicating factor is that the result has to be given to the child and the parents. However, here too we assume that 'disclosure at home' might be preferred by many parents and children to a visit to the outpatient clinic. Further study for this group is recommended.
In conclusion, we show in a large dataset that offering a choice how to receive a pre-symptomatic DNA result, either face-to-face or by letter with an optional face-to-face consultation afterwards, improves patient satisfaction, does not impede the quality of the counselling procedure, nor the psychological well-being of the counselees. Moreover, it improves counselling efficiency for both counselee and counsellor. Our findings may have important implications for the field of pre-symptomatic testing for adult-onset disorders in clinical genetics. Instead of following an identical approach for everyone, it could be considered to assess the risk population which requires additional psychosocial support. The normal population who, most of the time, experience no serious psychological impact of the DNA test, could be offered a choice to receive the result face-to-face or by letter.
